This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Levetiracetam

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20230927

Version

6

Spl Product Data Elements

levetiracetam levetiracetam LEVETIRACETAM LEVETIRACETAM HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO POVIDONE CELLULOSE, MICROCRYSTALLINE STARCH, CORN WHITE TO OFF-WHITE OVAL ZE;32 levetiracetam levetiracetam LEVETIRACETAM LEVETIRACETAM HYPROMELLOSES MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO POVIDONE CELLULOSE, MICROCRYSTALLINE STARCH, CORN WHITE TO OFF-WHITE OVAL ZE;35

Application Number

ANDA078918

Brand Name

Levetiracetam

Generic Name

levetiracetam

Product Ndc

65841-703

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-703-19 in bottle of 120 tablets Levetiracetam Tablets, 250 mg Rx only NDC 65841-704-10 Levetiracetam Tablets, 1000 mg 1000 tablets Rx only IMAGE image

Spl Medguide

Manufactured by: Cadila Healthcare Ltd. India

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.